|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 47/02 | (2006.01) | ||
| A61K 9/08 | (2006.01) | ||
| A61K 31/215 | (2006.01) | ||
| A61P 31/04 | (2006.01) |
| (11) | Number of the document | 3310331 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16729258.0 |
| Date of filing the European patent application | 2016-06-14 | |
| (97) | Date of publication of the European application | 2018-04-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-14 |
| (46) | Date of publication of the claims translation | 2021-01-11 |
| (86) | Number | PCT/EP2016/063609 |
| Date | 2016-06-14 |
| (87) | Number | WO 2016/202788 |
| Date | 2016-12-22 |
| (30) | Number | Date | Country code |
| 201562180871 P | 2015-06-17 | US |
| (72) |
FERENCIC, Mathias, AT
HEILMAYER, Werner, AT
HINSMANN, Peter, AT
WICHA, Wolfgang, AT
|
| (73) |
Nabriva Therapeutics GMBH,
Leberstra e 20, 1110 Wien,
AT
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Švirkščiamos lefamulino farmacinės kompozicijos |
| INJECTABLE PHARMACEUTICAL FORMULATIONS OF LEFAMULIN |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 10 | 231.00 EUR |
| 2026-06-14 |